Binding of these targets was validated by anti-HuD antibody versus isotype control antibody immunoprecipitation, followed by qPCR in NB cell lines, IMR-32, SK-N-DZ and SK-N-SH (Fig. S4A and B). Here, ELAVL4 is linked to neuroblastoma.